SCHEMBL955897

SCHEMBL955897

C=C(C)C=COC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1783345 0.80
SCHEMBL4865125 0.80
Hydrogen Peroxide SCHEMBL27141842 0.78 ALDH1A1 (0.36)
SCHEMBL28605739 0.76
SCHEMBL4619432 0.76 ALDH1A1 (0.44)
SCHEMBL7159941 0.74 ALDH1A1 (0.37)
SCHEMBL7159946 0.74 ALDH1A1 (0.37)
SCHEMBL10974684 0.73 TDP1 (0.32)
SCHEMBL16986440 0.73 ALDH1A1 (0.31)
SCHEMBL10974682 0.73 TDP1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604301-B1 p-Di[2-chloroethyl)amino]phenylalanine derivatives process for their preparation and pharmaceutical compositions containing them ADIR (FR) 1996-05-29 EP claimed
CN-114341110-A Aminothiol ester compound and use thereof 高级生物设计公司 2022-04-12 CN disclosed
US-9382242-B2 Preparation and use of compounds as protease inhibitors MERCK SHARP & DOHME CORP. (US) 2016-07-05 US disclosed
EP-1996548-B1 SIGMA RECEPTOR COMPOUNDS ESTEVE LABOR DR (ES) 2016-01-06 EP disclosed
US-20140206715-A1 PREPARATION AND USE OF COMPOUNDS AS PROTEASE INHIBITORS PHARMACOPEIA, LLC 2014-07-24 US disclosed
US-8722708-B2 Substituted isoindolines as aspartyl protease inhibitors Merck Sharp & Dohme Inc. (US) 2014-05-13 US disclosed
EP-2345411-B1 Heterocyclic aspartyl protease inhibitors, preparation and use thereof MERCK SHARP & DOHME (US) 2013-10-02 EP disclosed
US-8492563-B2 4,5,6,7-tetrahydrobenzo[B]thiophene derivatives and their use as sigma receptor ligands LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-07-23 US disclosed
US-8481567-B2 Sigma receptor compounds LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-07-09 US disclosed
US-8394797-B2 Substituted pyrazole sigma receptor antagonists LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2013-03-12 US disclosed
US-20080176868-A1 pyrrole/pyrimidine-2-imine fused ring derivatives; aspartyl proteases, beta-secretase inhibitor; cardiovascular diseases, cognitive and neurodegenerative diseases such as Alzheimer's, Human Immunodeficiency Virus, plasmepins, cathepsin D and protozoal enzymes SCHERING CORPORATION 2008-07-24 US disclosed
EP-1896032-A2 THE PREPARATION AND USE OF COMPOUNDS AS PROTEASE INHIBITORS SCHERING CORPORATION (US) 2008-03-12 EP disclosed
US-20070232585-A1 Sigma Receptor Inhibitors LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-10-04 US disclosed
WO-2007098961-A1 4, 5, 6,7-TETRAHYDROBENZO[B]THIOPHENE DERIVATIVES AND THEIR USE AS SIGMA RECEPTOR LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-09-07 WO disclosed
WO-2007098962-A1 SIGMA RECEPTOR COMPOUNDS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2007-09-07 WO disclosed
EP-1829869-A1 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-09-05 EP disclosed
EP-1781619-A1 SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-05-09 EP disclosed
WO-2006138265-A2 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS, PREPARATION AND USE THEREOF SCHERING CORPORATION (US) 2006-12-28 WO disclosed
WO-2006021463-A1 SIGMA RECEPTOR INHIBITORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2006-03-02 WO disclosed
US-5424464-A Used for treating leukemia ADIR ET COMPAGNIE (FR) 1995-06-13 US disclosed